Knee surgery pain study tests best route for common Anti-Inflammatory
NCT ID NCT07180953
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial looked at whether giving dexamethasone through a nerve block or through a vein works better for pain and inflammation after total knee replacement. 90 older adults were randomly assigned to one of two groups. Researchers measured how long pain relief lasted, total opioid use, and pain scores.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexamethasone
- What this could lead to
- If it works, this could show that giving dexamethasone directly in the nerve block provides better pain relief and less inflammation after knee replacement surgery.
- What could go wrong
- This is a small, completed Phase 4 trial with 90 participants, so results may not apply to everyone. The difference between routes may be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
90 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients scheduled for total knee arthroplasty * patients aged \>65 and \<100 years * patients can provide informed consent * patients can reliably report symptoms to the research team Exclusion Criteria: * inability to provide first-party consent due to cognitive impairment or a * language barrier * infection at the site of the regional block, * coagulation disorders, * immunodeficiency, * American Society of Anesthesiologists (ASA) physical status of IV or higher, * history of regular steroid medication.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthropathy of knee are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poznan University of Medical Sciences
Poznan, 62-701, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking daily life with knee osteoarthritis improve care?
- Physical therapy may unlock lasting activity for older adults with joint pain
- Gout drug may take the sting out of knee replacement recovery
- Can a single gene shot rebuild Worn-Out knees?
- Can a daily drink soothe aching knees?
- Can collagen supplements ease the deep pain of knee osteoarthritis?